BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1159 related articles for article (PubMed ID: 19639604)

  • 1. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
    Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.
    Sanchez AM; Csibi A; Raibon A; Cornille K; Gay S; Bernardi H; Candau R
    J Cell Biochem; 2012 Feb; 113(2):695-710. PubMed ID: 22006269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes.
    Nakashima K; Yakabe Y
    Biosci Biotechnol Biochem; 2007 Jul; 71(7):1650-6. PubMed ID: 17617726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin down-regulates the expression of ubiquitin E3 ligases partially by inhibiting the activity and expression of AMP-activated protein kinase in L6 myotubes.
    Deng HP; Chai JK; Shen CA; Zhang XB; Ma L; Sun TJ; Hu QG; Chi YF; Dong N
    Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26193886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine Regulates Protein Turnover by Activating Protein Kinase B/Mammalian Target of Rapamycin and by Inhibiting MuRF1 and Atrogin-1 Gene Expression in C2C12 Myoblasts.
    Sun K; Wu Z; Ji Y; Wu G
    J Nutr; 2016 Dec; 146(12):2461-2467. PubMed ID: 27798331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
    Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
    Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
    Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of autophagy and ubiquitin-proteasome pathways during ultra-endurance running.
    Jamart C; Francaux M; Millet GY; Deldicque L; Frère D; Féasson L
    J Appl Physiol (1985); 2012 May; 112(9):1529-37. PubMed ID: 22345427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
    Chen B; Wu Q; Xiong Z; Ma Y; Yu S; Chen D; Huang S; Dong Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes.
    Wang DT; Yin Y; Yang YJ; Lv PJ; Shi Y; Lu L; Wei LB
    Int Immunopharmacol; 2014 Apr; 19(2):206-13. PubMed ID: 24534773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
    Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy
    Wang M; Jiang R; Liu J; Xu X; Sun G; Zhao D; Sun L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
    Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells.
    Nishimura Y; Chunthorng-Orn J; Lord S; Musa I; Dawson P; Holm L; Lai YC
    Am J Physiol Cell Physiol; 2022 Jul; 323(1):C215-C225. PubMed ID: 35704697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats.
    Sheriff S; Kadeer N; Joshi R; Friend LA; James JH; Balasubramaniam A
    Mol Cell Endocrinol; 2012 Apr; 351(2):286-95. PubMed ID: 22266196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
    Thomson DM; Fick CA; Gordon SE
    J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.